4-5

AUROBINDO PHARMA LTD' (APL). APL is a growing Indian multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations. APL is 2nd Largest Generic Company as per Rx dispensed in the USA.APL is Amongst Top 10 Generic player in France, Germany, Portugal, UK, Italy, Czech Republic, Netherlands & Belgium. APL manufactured 33 Billion+ diverse dosage forms in 2018-19. APL has 27 manufacturing facilities and 5 R&D centres worldwide.

Post : Executive Production and Packing (OSD Only)

Caring for the world, one person at a time has inspired and united the people of Johnson & Johnson for over 125 years. We embrace research and science -- bringing creative ideas, products, and services to advance the health and well-being of people. Every single day, our more than 130,000 employees across the world are blending heart, science, and ingenuity to profoundly change the trajectory of health for humanity.

Post : Complaint Vigilance Analyst

Medreich is a fully integrated pharmaceutical company with an established presence across the globe. The company is involved in the CMO & CDMO business of pharmaceutical preparations in various dosage forms catering to diverse Therapeutic categories.  Medreich has an advanced state of the art Research and Development centre with proven scientific competence to develop formulations as Patent Non-infringing and Niche generics in differentiated dosage form for global regulated markets.

AUROBINDO PHARMA LTD' (APL). APL is a growing Indian multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations. APL is 2nd Largest Generic Company as per Rx dispensed in the USA.APL is Amongst Top 10 Generic player in France, Germany, Portugal, UK, Italy, Czech Republic, Netherlands & Belgium. APL manufactured 33 Billion+ diverse dosage forms in 2018-19. APL has 27 manufacturing facilities and 5 R&D centres worldwide.

Post : Quality Control (QC) Executive/Sr Executive (Pharma Formulations OSD)

WNS (Holdings) Limited is a leading Business Process Management (BPM) company. We combine our deep industry knowledge with technology and analytics expertise to co-create innovative, digital-led transformational solutions with clients across 10 industries. We enable businesses in Travel, Insurance, Banking and Financial Services, Manufacturing, Retail and Consumer Packaged Goods, Shipping and Logistics, Healthcare, and Utilities to re-imagine their digital future and transform their outcomes with operational excellence.

Post : Scientific Writer

Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Backed by over 25 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, Generics, Biosimilars, Custom Pharmaceutical services and Branded Generics.

Mankind Pharma, the 7^th largest Pharmaceutical Company of India, was incepted in 1995 with a meagre capital of 50 lakhs and 20 employees. Today, we are amongst the top 5 fastest growing Pharmaceutical companies of India with an employee base of more than 10000 and heading towards a turnover of  INR 3000 crores.

Post : Officer/Senior Officer

MSN Group is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs) and Finished dosages in India. Established in the year 2003, MSN Group comprises of 330 API manufacturing plants (including one for Oncology), three finished dosage facility ( including one for Oncology)and a dedicated R&D Center . Our plants are ISO 9001-2000 certified, WHO: GMP, EU:GMP and USFDA approved. Our manufacturing units are designed to confirm to the principles of Quality, Safety and sound Environment.

MSN Group is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs) and Finished dosages in India. Established in the year 2003, MSN Group comprises of 330 API manufacturing plants (including one for Oncology), three finished dosage facility ( including one for Oncology)and a dedicated R&D Center . Our plants are ISO 9001-2000 certified, WHO: GMP, EU:GMP and USFDA approved. Our manufacturing units are designed to confirm to the principles of Quality, Safety and sound Environment.